Professor Thomas Dorner, M.D.

Thomas Dörner is Professor of Rheumatology and Clinical Immunology for Innovative Therapies at Charité Universitätsmedizin Berlin, Germany and group leader of the B-cell memory group at the German Rheumatism Research Center Berlin (DRFZ). He is also board certified in Transfusion Medicine and Hemostaseology and leads the coagulation service at Charité hospitals. After his residency at Charité Universitätsmedizin Berlin, he spent a post-doctoral fellowship at the University of Texas, Southwestern Medical Center at Dallas. There he started research on the molecular aspects of the B-cell receptor gene usage in autoimmune diseases which subsequently evolved into comprehensive studies of the role of B-cells in autoimmunity including defining targets of treatment.

Professor Dörner has a professorship for Innovative therapeutics in Autoimmune Diseases at Charité Universitätsmedizin Berlin. His current main research topics comprise translational projects in autoimmune diseases with a main focus on the role of cytokines on B-cell functions, check-point molecule interactions between B- and T-cells, and searching for genetic modulation of B and plasma cell differentiation as a treatment option.

Professor Dörner has received a number of international and national awards, including the Senior Scholar Award of the American Society of Rheumatology, the H Schultze Award of the German League against Rheumatism, the Schoen Award of the German Society of Rheumatology, and the Fischer Prize by the NIH.

He has served as a member of editorial boards of leading journals in rheumatology, including Arthritis & Rheumatism, Arthritis Research & Therapy, Annals of the Rheumatic Diseases, Lupus Science and Medicine, Current Reviews in Rheumatology, Brazilian Journal of Rheumatology, Rheumatology Reviews, European Journal of Immunology and Zeitschrift für Rheumatologie.